共 50 条
[41]
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
[J].
Forero, Andres
;
Bendell, Johanna C.
;
Kumar, Prasanna
;
Janisch, Linda
;
Rosen, Michael
;
Wang, Qiang
;
Copigneaux, Catherine
;
Desai, Madhuri
;
Senaldi, Giorgio
;
Maitland, Michael L.
.
INVESTIGATIONAL NEW DRUGS,
2017, 35 (03)
:298-306

Forero, Andres
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Bendell, Johanna C.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, 250 25th Ave N,Suite 200, Nashville, TN 37203 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Kumar, Prasanna
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Janisch, Linda
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Rosen, Michael
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Wang, Qiang
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Copigneaux, Catherine
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Desai, Madhuri
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA
Eli Lilly & Co, 440 Route 22 East, Bridgewater, NJ 08807 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Senaldi, Giorgio
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Inc, 399 Thornall St, Edison, NJ 08837 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

Maitland, Michael L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
Inova Schar Canc Inst, 3289 Woodburn Rd, Annandale, VA 22003 USA Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[42]
Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors
[J].
Doi, Toshihiko
;
Tamura, Kenji
;
Tanabe, Yuko
;
Yonemori, Kan
;
Yoshino, Takayuki
;
Fuse, Nozomu
;
Kodaira, Makoto
;
Bando, Hideaki
;
Noguchi, Kazuo
;
Shimamoto, Takashi
;
Ohtsu, Atsushi
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2015, 76 (02)
:409-416

Doi, Toshihiko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Tamura, Kenji
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Tanabe, Yuko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Yonemori, Kan
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Yoshino, Takayuki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Fuse, Nozomu
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Kodaira, Makoto
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Bando, Hideaki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Noguchi, Kazuo
论文数: 0 引用数: 0
h-index: 0
机构:
MSD KK, Chiyoda Ku, Tokyo 1028667, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Shimamoto, Takashi
论文数: 0 引用数: 0
h-index: 0
机构:
MSD KK, Chiyoda Ku, Tokyo 1028667, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan

Ohtsu, Atsushi
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan
[43]
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
[J].
Dees, E. Claire
;
Infante, Jeffrey R.
;
Cohen, Roger B.
;
O'Neil, Bert H.
;
Jones, Suzanne
;
von Mehren, Margaret
;
Danaee, Hadi
;
Lee, Yih
;
Ecsedy, Jeffrey
;
Manfredi, Mark
;
Galvin, Katherine
;
Stringer, Bradley
;
Liu, Hua
;
Eton, Omar
;
Fingert, Howard
;
Burris, Howard
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2011, 67 (04)
:945-954

Dees, E. Claire
论文数: 0 引用数: 0
h-index: 0
机构:
Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Infante, Jeffrey R.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Cohen, Roger B.
论文数: 0 引用数: 0
h-index: 0
机构:
Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

O'Neil, Bert H.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Jones, Suzanne
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

von Mehren, Margaret
论文数: 0 引用数: 0
h-index: 0
机构:
Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Danaee, Hadi
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Lee, Yih
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA
Forest Res Inst Inc, Jersey City, NJ USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Ecsedy, Jeffrey
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Manfredi, Mark
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Galvin, Katherine
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Stringer, Bradley
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Liu, Hua
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Eton, Omar
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA
Boston Univ, Sch Med, Boston, MA 02118 USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Fingert, Howard
论文数: 0 引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Cambridge, MA USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

Burris, Howard
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[44]
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
[J].
E. Claire Dees
;
Jeffrey R. Infante
;
Roger B. Cohen
;
Bert H. O’Neil
;
Suzanne Jones
;
Margaret von Mehren
;
Hadi Danaee
;
Yih Lee
;
Jeffrey Ecsedy
;
Mark Manfredi
;
Katherine Galvin
;
Bradley Stringer
;
Hua Liu
;
Omar Eton
;
Howard Fingert
;
Howard Burris
.
Cancer Chemotherapy and Pharmacology,
2011, 67
:945-954

E. Claire Dees
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Jeffrey R. Infante
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Roger B. Cohen
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Bert H. O’Neil
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Suzanne Jones
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Margaret von Mehren
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Hadi Danaee
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Yih Lee
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Jeffrey Ecsedy
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Mark Manfredi
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Katherine Galvin
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Bradley Stringer
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Hua Liu
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Omar Eton
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Howard Fingert
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center

Howard Burris
论文数: 0 引用数: 0
h-index: 0
机构: University of North Carolina,UNC Lineberger Comprehensive Cancer Center
[45]
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
[J].
Jih-Hsiang Lee
;
Tom Wei-Wu Chen
;
Chih-Hung Hsu
;
Yu-Hsin Yen
;
James Chih-Hsin Yang
;
Ann-Lii Cheng
;
Shun-ichi Sasaki
;
LiYin (Lillian) Chiu
;
Masahiro Sugihara
;
Tomoko Ishizuka
;
Toshihiro Oguma
;
Naoyuki Tajima
;
Chia-Chi Lin
.
Investigational New Drugs,
2020, 38
:99-110

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Chih-Hung Hsu
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

论文数: 引用数:
h-index:
机构:

James Chih-Hsin Yang
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

Ann-Lii Cheng
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

Shun-ichi Sasaki
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

LiYin (Lillian) Chiu
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

Masahiro Sugihara
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

论文数: 引用数:
h-index:
机构:

Toshihiro Oguma
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

Naoyuki Tajima
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,

Chia-Chi Lin
论文数: 0 引用数: 0
h-index: 0
机构: National Taiwan University Hospital,
[46]
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
[J].
Lee, Jih-Hsiang
;
Chen, Tom Wei-Wu
;
Hsu, Chih-Hung
;
Yen, Yu-Hsin
;
Yang, James Chih-Hsin
;
Cheng, Ann-Lii
;
Sasaki, Shun-ichi
;
Chiu, LiYin
;
Sugihara, Masahiro
;
Ishizuka, Tomoko
;
Oguma, Toshihiro
;
Tajima, Naoyuki
;
Lin, Chia-Chi
.
INVESTIGATIONAL NEW DRUGS,
2020, 38 (01)
:99-110

Lee, Jih-Hsiang
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Chen, Tom Wei-Wu
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Hsu, Chih-Hung
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan
Natl Taiwan Univ, Coll Med, Grad Inst Oncol, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Yen, Yu-Hsin
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Yang, James Chih-Hsin
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan
Natl Taiwan Univ, Coll Med, Grad Inst Oncol, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Cheng, Ann-Lii
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan
Natl Taiwan Univ, Coll Med, Grad Inst Oncol, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Sasaki, Shun-ichi
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Chiu, LiYin
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, 7F-1,308,Sec 2,Bade Rd, Taipei 104, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Sugihara, Masahiro
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Ishizuka, Tomoko
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Oguma, Toshihiro
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Tajima, Naoyuki
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan

Lin, Chia-Chi
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Taiwan Univ Hosp, 7 Chung Shan S Rd, Taipei 10002, Taiwan
Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, 7 Chung Shan S Rd, Taipei 10002, Taiwan Natl Taiwan Univ Hosp, Hsin Chu Branch 25, Lane 442,Sec 1,Jingguo Rd, Hsinchu 300, Taiwan
[47]
Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
[J].
Choi, Jiwon
;
Park, Jiyoung
;
Cho, Ilyoung
;
Sheen, Yhunyhong
.
RADIOLOGY AND ONCOLOGY,
2022, 56 (02)
:185-197

Choi, Jiwon
论文数: 0 引用数: 0
h-index: 0
机构:
Ewha Womans Univ, Coll Pharm, Seoul, South Korea
Korea Inst Toxicol, Natl Ctr Efficacy Evaluat Resp Dis Prod, Daejeon, South Korea Ewha Womans Univ, Coll Pharm, Seoul, South Korea

论文数: 引用数:
h-index:
机构:

Cho, Ilyoung
论文数: 0 引用数: 0
h-index: 0
机构:
Ewha Womans Univ, Coll Pharm, Seoul, South Korea Ewha Womans Univ, Coll Pharm, Seoul, South Korea

Sheen, Yhunyhong
论文数: 0 引用数: 0
h-index: 0
机构:
Ewha Womans Univ, Coll Pharm, Seoul, South Korea Ewha Womans Univ, Coll Pharm, Seoul, South Korea
[48]
Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors
[J].
Apostolia Maria Tsimberidou
;
Michelle A. Rudek
;
David Hong
;
Chaan S. Ng
;
Jessica Blair
;
Howard Goldsweig
;
Razelle Kurzrock
.
Cancer Chemotherapy and Pharmacology,
2010, 65
:235-241

Apostolia Maria Tsimberidou
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

Michelle A. Rudek
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

David Hong
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

Chaan S. Ng
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

Jessica Blair
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

Howard Goldsweig
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics

Razelle Kurzrock
论文数: 0 引用数: 0
h-index: 0
机构: The University of Texas M. D. Anderson Cancer Center,Phase I Program, Department of Investigational Cancer Therapeutics
[49]
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors
[J].
Yap, T. A.
;
Choudhury, A. D.
;
Hamilton, E.
;
Rosen, L. S.
;
Stratton, K. L.
;
Gordon, M. S.
;
Schaer, D.
;
Liu, L.
;
Zhang, L.
;
Mittapalli, R. K.
;
Zhong, W.
;
Soman, N.
;
Tolcher, A. W.
.
ESMO OPEN,
2024, 9 (09)

Yap, T. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Choudhury, A. D.
论文数: 0 引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Hamilton, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Breast & Gynecol Res Program, Nashville, TN USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Rosen, L. S.
论文数: 0 引用数: 0
h-index: 0
机构:
UCLA Hematol Oncol, Div Hematol & Oncol, Santa Monica, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Stratton, K. L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA
Stephenson Canc Ctr, Oklahoma City, OK USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Gordon, M. S.
论文数: 0 引用数: 0
h-index: 0
机构:
HonorHlth Res Inst, Scottsdale, AZ USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Schaer, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer, Oncol Translat Sci, Pearl River, NY USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Liu, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer, Oncol Translat Sci, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Zhang, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Oncol Res Unit, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Mittapalli, R. K.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Clin Pharmacol, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Zhong, W.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer, Oncol Biostat, Cambridge, MA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Soman, N.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer, Clin Res, Thousand Oaks, CA USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA

Tolcher, A. W.
论文数: 0 引用数: 0
h-index: 0
机构:
NEXT Oncol, Clin Res, San Antonio, TX USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX USA
[50]
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
[J].
Cassier, Philippe A.
;
Borad, Mitesh J.
;
Sharma, Sunil
;
Dubois, Bertrand
;
Caux, Christophe
;
Okano, Fumiyoshi
;
Von Hoff, Daniel D.
;
Blay, Jean-Yves
.
CANCER RESEARCH COMMUNICATIONS,
2025, 5 (07)
:1119-1128

Cassier, Philippe A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France
Ctr Rech Cancerol Lyon CRCL, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Borad, Mitesh J.
论文数: 0 引用数: 0
h-index: 0
机构:
Mayo Clin Arizona, Mayo Clin, Dept Hematol Oncol, Comprehens Canc Ctr, Phoenix, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Sharma, Sunil
论文数: 0 引用数: 0
h-index: 0
机构:
HonorHlth Res Inst, Scottsdale, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Dubois, Bertrand
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Claude Bernard Lyon 1, Ctr Rech Cancerol Lyon CRCL, Ctr Leon Berard, Lyon Immunotherapy Canc Lab,INSERM U1052 CNRS UMR, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Caux, Christophe
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Claude Bernard Lyon 1, Ctr Rech Cancerol Lyon CRCL, Ctr Leon Berard, Lyon Immunotherapy Canc Lab,INSERM U1052 CNRS UMR, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Okano, Fumiyoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Japan Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Von Hoff, Daniel D.
论文数: 0 引用数: 0
h-index: 0
机构:
Translat Genom Res Inst TGen, Phoenix, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Blay, Jean-Yves
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Leon Berard & Ctr Rech Cancerol Lyon CRCL, Dept Med Oncol, Lyon, France
Univ Claude Bernard Lyon 1, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France